ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 153 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,458 | +61.0% | 912 | +25.6% | 0.00% | – |
| Q1 2023 | $5,874 | – | 726 | +764.3% | 0.00% | – |
| Q1 2020 | $0 | – | 84 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 84 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 84 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 84 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 84 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 84 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | -99.0% | 84 | -99.2% | 0.00% | – |
| Q2 2018 | $199,000 | +40.1% | 9,903 | +22.7% | 0.00% | – |
| Q1 2018 | $142,000 | -28.3% | 8,068 | +0.0% | 0.00% | – |
| Q4 2017 | $198,000 | -2.9% | 8,066 | +2.1% | 0.00% | – |
| Q3 2017 | $204,000 | -18.4% | 7,900 | -14.3% | 0.00% | – |
| Q2 2017 | $250,000 | +14.7% | 9,220 | +26.0% | 0.00% | – |
| Q1 2017 | $218,000 | +73.0% | 7,320 | +57.8% | 0.00% | – |
| Q4 2016 | $126,000 | – | 4,640 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 441,000 | $833,000 | 2.78% |
| MFN Partners Management, LP | 4,000,000 | $7,560,000 | 1.56% |
| Endurant Capital Management LP | 2,055,069 | $3,884,000 | 1.22% |
| Broadfin Capital, LLC | 1,888,039 | $3,568,000 | 0.48% |
| Aisling Capital Management LP | 634,455 | $1,199,000 | 0.46% |
| EcoR1 Capital, LLC | 2,087,312 | $3,945,000 | 0.36% |
| Sofinnova Investments, Inc. | 1,911,573 | $3,613,000 | 0.26% |
| Alambic Investment Management, L.P. | 115,036 | $217,000 | 0.18% |
| Parkman Healthcare Partners LLC | 225,000 | $425,000 | 0.12% |
| Rock Springs Capital Management LP | 1,600,000 | $3,024,000 | 0.10% |